{"hands_on_practices": [{"introduction": "Translating the molecular process of class switch recombination (CSR) into a measurable outcome is a fundamental skill in experimental immunology. This first practice exercise challenges you to interpret flow cytometry data, a cornerstone technique for analyzing cell populations, to quantify the efficiency of CSR in a B cell culture. By carefully accounting for transient, double-positive intermediates, you will derive the frequency of cells that have successfully completed the switch, honing your ability to connect experimental readouts to underlying biological events [@problem_id:2858720].", "problem": "A purified population of murine naive B lymphocytes is stimulated in vitro under conditions that induce Class Switch Recombination (CSR) to immunoglobulin G subclass 1 (IgG1). Class Switch Recombination (CSR) is defined as the recombination-driven replacement of the immunoglobulin heavy chain constant region, which changes the isotype (for example, from immunoglobulin M (IgM) to immunoglobulin G subclass 1 (IgG1)) without altering the antigen-binding variable region. Flow cytometry is used to quantify surface immunoglobulin heavy chain isotypes at baseline and after stimulation. Assume the following scientifically standard measurement and biological premises as the foundation for quantification:\n- CSR yields gain of the IgG1 constant region and, upon completion, loss of the IgM constant region on the same heavy chain locus.\n- Flow cytometry detects surface protein; cells undergoing CSR can transiently co-express both isotypes, producing an IgM-positive and IgG1-positive double-positive population.\n- Percentages reported for an isotype gate include any double-positive cells that fall within that gate.\n- The total live B-cell fraction remains stable across the measurement interval, and the emergence of immunoglobulin G subclass 1 (IgG1)-positive cells at the endpoint arises from CSR among the initially immunoglobulin M (IgM)-positive B cells.\n- Baseline immunoglobulin G subclass 1 (IgG1) positivity is negligible.\n\nYou are given the following flow cytometry observations:\n- At baseline, the fraction of immunoglobulin M (IgM)-positive cells is $90\\%$.\n- At $72$ hours, the fraction of immunoglobulin M (IgM)-positive cells is $40\\%$, the fraction of immunoglobulin G subclass 1 (IgG1)-positive cells is $50\\%$, and the immunoglobulin M (IgM)-positive and immunoglobulin G subclass 1 (IgG1)-positive double-positive fraction is $10\\%$.\n\nOperationally define the CSR frequency to immunoglobulin G subclass 1 (IgG1) as the fraction of the initially immunoglobulin M (IgM)-positive cohort that has completed CSR to immunoglobulin G subclass 1 (IgG1) by the $72$-hour time point, where completion is indicated by cells that are immunoglobulin G subclass 1 (IgG1)-positive and immunoglobulin M (IgM)-negative at $72$ hours. Compute this CSR frequency using only the given measurements. Express your final answer as a unitless decimal. Round your answer to three significant figures.", "solution": "The problem requires the computation of the Class Switch Recombination (CSR) frequency to immunoglobulin G subclass 1 (IgG1), based on flow cytometry data from an in vitro B lymphocyte culture. The problem statement has been validated and found to be scientifically sound, consistent, and well-posed. We may proceed with the solution.\n\nLet the total population of live B lymphocytes be normalized to $1$. The fractions given in the problem represent subpopulations relative to this total. We define the following variables based on the provided data:\n\n- $M_0$: The fraction of immunoglobulin M (IgM)-positive cells at the baseline time point ($t=0$). From the problem, $M_0 = 0.90$.\n- $M_{72}$: The fraction of IgM-positive cells at the $72$-hour time point. From the problem, $M_{72} = 0.40$.\n- $G_{72}$: The fraction of IgG1-positive cells at the $72$-hour time point. From the problem, $G_{72} = 0.50$.\n- $(M \\cap G)_{72}$: The fraction of cells that are double-positive for both IgM and IgG1 at the $72$-hour time point. From the problem, $(M \\cap G)_{72} = 0.10$.\n\nThe CSR frequency, which we denote as $F_{CSR}$, is operationally defined as the fraction of the initially IgM-positive cohort that has completed CSR by the $72$-hour time point. Completion of CSR is indicated by cells that are IgG1-positive and IgM-negative.\n\nFirst, we must determine the fraction of the total cell population that has completed CSR. These are the cells that are IgG1-positive but IgM-negative at $t=72$ hours. Let us denote this fraction as $G_{sp}$, where 'sp' signifies 'single-positive' for IgG1. This population is the set of all IgG1-positive cells from which the double-positive (IgM-positive and IgG1-positive) cells have been excluded.\n\nThe total fraction of IgG1-positive cells, $G_{72}$, is the sum of two disjoint populations: the cells that are single-positive for IgG1 ($G_{sp}$) and the cells that are double-positive for both IgG1 and IgM ($(M \\cap G)_{72}$). This can be expressed as:\n$$G_{72} = G_{sp} + (M \\cap G)_{72}$$\nWe can solve for $G_{sp}$, the fraction of cells that have completed CSR:\n$$G_{sp} = G_{72} - (M \\cap G)_{72}$$\nSubstituting the given values:\n$$G_{sp} = 0.50 - 0.10 = 0.40$$\nThus, $40\\%$ of the total live B-cell population consists of cells that have completed CSR to IgG1.\n\nNext, we must construct the fraction for the CSR frequency, $F_{CSR}$. The definition specifies that this frequency is relative to the *initially* IgM-positive cohort. The size of this initial cohort, as a fraction of the total population, is given as $M_0$.\n$$M_0 = 0.90$$\nThe problem states that IgG1-positive cells emerge from the initial IgM-positive population. Therefore, the numerator of our frequency calculation is the fraction of cells that have completed CSR ($G_{sp}$), and the denominator is the fraction of cells that were initially IgM-positive ($M_0$).\n\nThe CSR frequency is therefore calculated as the ratio:\n$$F_{CSR} = \\frac{G_{sp}}{M_0}$$\nSubstituting the calculated and given values:\n$$F_{CSR} = \\frac{0.40}{0.90} = \\frac{4}{9}$$\nTo provide the final answer as a decimal rounded to three significant figures, we perform the division:\n$$F_{CSR} \\approx 0.4444...$$\nRounding to three significant figures, we obtain:\n$$F_{CSR} \\approx 0.444$$\nThis value represents the fraction of the original IgM-bearing B cells that have successfully switched to producing IgG1 and ceased producing IgM by the $72$-hour mark.", "answer": "$$\\boxed{0.444}$$", "id": "2858720"}, {"introduction": "Beyond quantifying its frequency, a deep understanding of CSR requires grasping its irreversible nature at the genomic level. This problem presents a scenario with different pathways to the same final isotype, forcing a focus on the fundamental rule of deletional recombination [@problem_id:2858655]. This exercise sharpens your conceptual reasoning by testing whether you can distinguish essential mechanistic principles from distracting details.", "problem": "B cells undergoing class switch recombination (CSR) at the immunoglobulin heavy-chain (IgH) locus use recombination between switch (S) regions to loop out and delete the intervening constant region DNA, driven by Activation-Induced Cytidine Deaminase (AID). Consider a simplified linear IgH locus segment in which the relevant constant regions appear in the order $S\\mu$–$C\\mu$–$S\\gamma 1$–$C\\gamma 1$–$S\\alpha$–$C\\alpha$, and assume all switch regions are in the same transcriptional orientation so that CSR is deletional. A population of activated B cells is driven to produce immunoglobulin A (IgA) by CSR. In this population, $60$ percent of cells complete IgA switching by a single direct $S\\mu$–$S\\alpha$ join, while $40$ percent complete IgA switching via a two-step pathway that first joins $S\\mu$–$S\\gamma 1$ and then $S\\gamma 1$–$S\\alpha$. Under these conditions, and using only the described mechanistic properties of CSR (that recombination between two S regions deletes the intervening DNA on the chromosome), compute the expected fraction of cells that retain the $C\\gamma 1$ exons on the chromosome after they have completed switching to IgA. Express your answer as a decimal fraction with no units. No rounding is necessary.", "solution": "The problem is subjected to validation and is found to be valid. It is scientifically grounded in the principles of immunology, specifically class switch recombination (CSR), and is well-posed, providing all necessary information for a unique solution.\n\nThe central principle of this problem is the mechanism of deletional class switch recombination at the immunoglobulin heavy-chain (IgH) locus. The problem states that the relevant gene segments are arranged linearly in the order $S\\mu$–$C\\mu$–$S\\gamma 1$–$C\\gamma 1$–$S\\alpha$–$C\\alpha$. It explicitly defines the mechanistic rule: \"recombination between two S regions deletes the intervening DNA on the chromosome.\" The objective is to determine the fraction of a B cell population that retains the $C\\gamma 1$ exons on the chromosome after completing a switch to produce immunoglobulin A (IgA).\n\nWe are given two pathways by which an activated B cell, initially expressing IgM (utilizing the $C\\mu$ gene), can switch to expressing IgA (utilizing the $C\\alpha$ gene). Let us analyze the state of the $C\\gamma 1$ gene for each pathway.\n\nPathway 1: Direct $S\\mu$ to $S\\alpha$ switch.\nThis pathway is followed by a fraction $F_1 = 0.60$ of the cell population. The recombination event occurs between the $S\\mu$ switch region and the $S\\alpha$ switch region. According to the stated rule, the entire DNA segment located between $S\\mu$ and $S\\alpha$ is looped out and deleted from the chromosome. The initial configuration is:\n$$ \\text{... } S\\mu \\text{ – } C\\mu \\text{ – } S\\gamma 1 \\text{ – } C\\gamma 1 \\text{ – } S\\alpha \\text{ ...} $$\nThe segment `– Cμ – Sγ1 – Cγ1 –` lies between $S\\mu$ and $S\\alpha$. Upon recombination, this entire segment is excised. The resulting chromosome will have a hybrid $S\\mu/S\\alpha$ switch region followed by the $C\\alpha$ exons, allowing for IgA production. As the $C\\gamma 1$ gene is part of the deleted segment, it is not retained on the chromosome. For this subpopulation of cells, the fraction retaining $C\\gamma 1$ is $0$.\n\nPathway 2: Sequential $S\\mu \\to S\\gamma 1 \\to S\\alpha$ switch.\nThis pathway is followed by a fraction $F_2 = 0.40$ of the cell population. This process involves two distinct recombination events.\nStep (a): $S\\mu \\to S\\gamma 1$ recombination. In this step, the $S\\mu$ region recombines with the $S\\gamma 1$ region. The intervening DNA, which contains the $C\\mu$ gene, is deleted. The chromosomal configuration becomes:\n$$ \\text{... } S\\mu/S\\gamma 1 \\text{ – } C\\gamma 1 \\text{ – } S\\alpha \\text{ – } C\\alpha \\text{ ...} $$\nAt this intermediate stage, the cell produces IgG1, and the $C\\gamma 1$ gene is retained on the chromosome.\nStep (b): $S\\gamma 1 \\to S\\alpha$ recombination. The problem states that the cell then switches from producing IgG1 to IgA. This requires a second recombination event, this time between the newly formed hybrid switch region (which we can denote functionally as being upstream of $C\\gamma 1$) and the $S\\alpha$ region. The intervening DNA segment between these two points is now `– Cγ1 –`. This segment is deleted to bring the $S\\alpha$ and $C\\alpha$ regions into proximity with the upstream V(D)J exon and promoter elements.\nThe final chromosomal DNA for this pathway, which allows for IgA expression, has also had the $C\\gamma 1$ gene excised. Therefore, for this subpopulation of cells that have completed the full switch to IgA, the fraction retaining $C\\gamma 1$ is also $0$.\n\nThe problem asks for the expected fraction of cells that retain the $C\\gamma 1$ exons *after they have completed switching to IgA*. Let $R$ be the event that $C\\gamma 1$ is retained. The expected fraction is the weighted average of the outcomes from the two pathways:\n$$ E[\\text{fraction}] = F_1 \\times (\\text{fraction retaining } C\\gamma 1 \\text{ in Pathway 1}) + F_2 \\times (\\text{fraction retaining } C\\gamma 1 \\text{ in Pathway 2}) $$\nAs we have determined, the fraction of cells retaining $C\\gamma 1$ in the final IgA-switched state is $0$ for both pathways.\n$$ E[\\text{fraction}] = (0.60) \\times (0) + (0.40) \\times (0) $$\n$$ E[\\text{fraction}] = 0 + 0 = 0 $$\nTherefore, in a system governed by deletional CSR, any switch to a downstream isotype (like IgA) necessitates the excision of all intervening constant region genes (like $C\\gamma 1$). The different pathways and their frequencies are irrelevant to the final state of the $C\\gamma 1$ gene on the chromosome. No cell that has successfully switched to produce IgA can retain the $C\\gamma 1$ gene on the same chromosome. The expected fraction is $0$. The question requires the answer as a decimal fraction.", "answer": "$$\n\\boxed{0.0}\n$$", "id": "2858655"}, {"introduction": "At the heart of CSR lies a complex molecular machinery that converts the initial lesions made by Activation-induced cytidine deaminase (AID) into double-strand breaks. This final practice delves into this process by asking you to predict the distinct phenotypes that arise from deficiencies in two key parallel pathways, one dependent on Uracil-DNA Glycosylase (UNG) and the other on Mismatch Repair (MMR) [@problem_id:2858698]. Successfully navigating this problem demonstrates an integrated understanding of the molecular etiology of CSR, from DNA lesion to repair junction.", "problem": "An investigator compares immunoglobulin class switch recombination (CSR) in murine B cells lacking uracil-DNA glycosylase (UNG; $UNG^{-/-}$) or mutS homolog 2 (MSH2; $MSH2^{-/-}$). Cells are activated under conditions that induce robust germline transcription of multiple acceptor switch ($S$) regions and comparable proliferation. The investigator quantifies three readouts from the same cultures: (i) the mutation spectrum in switch-region DNA flanking double-strand break (DSB) junctions, (ii) the distribution of microhomology patch lengths at $S\\mu$–acceptor junctions, and (iii) the relative distribution of switched isotypes.\n\nUse the following foundational facts as the starting point for your reasoning. Activation-induced cytidine deaminase (AID) deaminates cytosines to uracils in transcribed switch regions, producing U:G mismatches. Uracil-DNA glycosylase (UNG) excises uracil to generate abasic sites, which are incised to produce nicks that can be converted into DSBs; this pathway tends to produce error signatures that include transversions at C:G pairs. The mismatch repair (MMR) system initiated by MSH2–MSH6 recognizes U:G mismatches and can recruit exonuclease activity to create gaps and nicks on the opposite strand, generating DSBs; this pathway underlies many A:T-base mutations during error-prone repair. CSR DSBs are resolved by classical non-homologous end-joining (NHEJ), but when end processing is impaired or ends are resected, microhomology-mediated alternative end-joining (alt-EJ) is engaged, which increases the average microhomology length at junctions. Isotype distribution depends on the efficiency of DSB formation and joining and on the intrinsic accessibility of individual $S$ regions (length of repeats and level of germline transcription).\n\nWhich option best predicts and differentiates the phenotypes observed in $UNG^{-/-}$ versus $MSH2^{-/-}$ B cells across the three readouts?\n\nA. $UNG^{-/-}$ B cells show a mutation spectrum dominated by $C \\to T$/$G \\to A$ transitions at C:G pairs with reduced C:G transversions; junctions exhibit a modest increase in microhomology relative to wild-type but shorter on average than in $MSH2^{-/-}$; residual CSR is skewed toward isotypes whose $S$ regions are highly transcribed and lengthy. $MSH2^{-/-}$ B cells retain C:G transversions due to UNG-dependent abasic site processing but display reduced A:T mutations; junctions show a pronounced increase in microhomology consistent with greater alt-EJ usage; isotype distribution is relatively preserved because UNG-driven DSB formation remains broadly competent across $S$ regions.\n\nB. $UNG^{-/-}$ B cells shift their mutation spectrum toward A:T-base mutations with increased C:G transversions; junction microhomology decreases due to more precise NHEJ; isotype usage is skewed toward isotypes with the shortest $S$ regions. $MSH2^{-/-}$ B cells show the opposite pattern for all three readouts.\n\nC. $MSH2^{-/-}$ B cells display a mutation spectrum dominated by A:T-base changes with fewer C:G transitions; junction microhomology is indistinguishable from wild-type; isotype usage is severely restricted because MMR is the sole producer of CSR DSBs. $UNG^{-/-}$ B cells show near-wild-type mutation spectra and isotype distributions.\n\nD. $UNG^{-/-}$ and $MSH2^{-/-}$ B cells have essentially identical mutation spectra and microhomology profiles because AID alone determines these properties; isotype distributions remain unchanged from wild-type under matched stimulation conditions.", "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded in the established principles of immunology, specifically the molecular mechanisms of immunoglobulin class switch recombination (CSR). The problem is well-posed, objective, and provides a sufficient set of foundational facts to permit a rigorous, deductive solution. We will therefore proceed with the analysis.\n\nThe central process is initiated by activation-induced cytidine deaminase (AID), which converts cytosine (C) to uracil (U) in transcribed switch (S) regions, creating U:G mismatches. The resolution of these mismatches into double-strand breaks (DSBs) necessary for CSR proceeds via two major, parallel pathways.\n\n1. The base excision repair (BER) pathway, initiated by uracil-DNA glycosylase (UNG). UNG excises the uracil, creating an abasic (apyrimidinic/apurinic) site. This site is subsequently nicked by an endonuclease, and an accumulation of such nicks can lead to a DSB. This pathway is mechanistically associated with the generation of transversion mutations at C:G pairs during error-prone repair.\n\n2. The mismatch repair (MMR) pathway, initiated by the MSH2–MSH6 complex recognizing the U:G mismatch. This recruits downstream factors, including exonucleases, which can generate nicks and gaps that are subsequently processed into DSBs. The problem states this pathway is a source of mutations at A:T base pairs during repair.\n\nThe resulting DSBs are joined primarily by classical non-homologous end-joining (NHEJ). If ends are damaged or processed abnormally, an alternative end-joining pathway (alt-EJ), which utilizes regions of microhomology, is engaged. This results in junctions with longer patches of microhomology.\n\nWe will now analyze the predicted phenotypes for each knockout based on these principles.\n\n**Analysis of $UNG^{-/-}$ Murine B Cells**\n\nIn the absence of UNG, the primary pathway for excising uracil is disabled. Consequently:\n\n- **Readout (i): Mutation Spectrum:** The U:G mismatches created by AID cannot be processed by the UNG-dependent pathway. Therefore, the mechanism leading to C:G transversions is severely impaired, and a sharp reduction in such mutations is expected. The persistent U:G mismatches will be resolved during DNA replication. If the strand containing U serves as a template, a $C:G \\to T:A$ transition mutation occurs. This leads to a mutation spectrum heavily dominated by $C \\to T$ (and $G \\to A$ on the complementary strand) transitions. The MSH2-dependent pathway remains active, but its primary effect is DSB formation and, as per the problem statement, generating A:T mutations, not resolving the primary U:G lesion into a transition. Thus, the defining feature is an increase in C:G transitions and a decrease in C:G transversions.\n\n- **Readout (ii): Microhomology at Junctions:** CSR is known to be severely impaired in $UNG^{-/-}$ B cells, as the UNG pathway is the major source of DSBs. The residual CSR relies on the less efficient MSH2-dependent pathway. Inefficient or delayed DSB formation can lead to altered DNA end structures that are poor substrates for classical NHEJ. The foundational facts stipulate that impaired end processing engages alt-EJ. Therefore, we predict an increased use of microhomology at the break junctions compared to wild-type cells.\n\n- **Readout (iii): Isotype Distribution:** Due to the profound defect in DSB formation, the overall efficiency of CSR is greatly reduced. For residual switching to occur, the system becomes highly dependent on the intrinsic properties of the acceptor S regions. S regions that are longer and more highly transcribed will accumulate a higher density of AID-induced lesions, stochastically increasing the probability that the inefficient backup pathway (MMR-dependent) can successfully generate a DSB. Consequently, the distribution of switched isotypes will be skewed toward those with the most \"accessible\" S regions (i.e., those with high germline transcription rates and greater length).\n\n**Analysis of $MSH2^{-/-}$ Murine B Cells**\n\nIn the absence of MSH2, the MMR pathway for processing U:G mismatches is disabled. Consequently:\n\n- **Readout (i): Mutation Spectrum:** The UNG-dependent pathway is fully intact and becomes the sole major pathway for processing U:G mismatches into DSBs. This pathway generates abasic sites, the processing of which is linked to C:G transversions. Therefore, C:G transversions will be retained. The problem also states that the MMR pathway underlies many A:T-base mutations. With MSH2 absent, this source of mutation is eliminated, leading to a reduction in mutations at A:T base pairs.\n\n- **Readout (ii): Microhomology at Junctions:** While the UNG pathway efficiently generates DSBs, MSH2 and the MMR machinery play roles in coordinating the broader DNA damage response, including the recruitment and regulation of repair factors for end-joining. The absence of MSH2 can lead to a defect in orchestrating clean ligation by NHEJ, resulting in aberrant end processing and increased resection. This shunts repair toward the alt-EJ pathway, leading to a pronounced increase in the average length of microhomology at junctions.\n\n- **Readout (iii): Isotype Distribution:** The principal mechanism for DSB formation in S regions, the UNG-dependent pathway, remains fully functional. Although overall CSR efficiency is reduced compared to wild-type, this pathway is \"broadly competent\" and can act on any S region targeted by AID. The relative efficiency of DSB formation across different S regions should therefore not be as drastically altered as in the $UNG^{-/-}$ case. As a result, the relative isotype distribution is expected to be largely preserved compared to wild-type cells.\n\n**Evaluation of Options**\n\n**A.** This option states:\n- For $UNG^{-/-}$: Spectrum dominated by $C \\to T$/$G \\to A$ transitions with reduced C:G transversions; modest increase in microhomology; skewing of isotypes toward highly transcribed, lengthy $S$ regions.\n- For $MSH2^{-/-}$: Retained C:G transversions with reduced A:T mutations; pronounced increase in microhomology; relatively preserved isotype distribution.\nThis option is entirely consistent with our derivations for both genotypes across all three readouts. The comparative statement that microhomology is shorter in $UNG^{-/-}$ than in $MSH2^{-/-}$ is also mechanistically sound, as the loss of MSH2 is known to cause a more severe end-joining defect.\n**Verdict: Correct.**\n\n**B.** This option claims for $UNG^{-/-}$ cells: a shift to A:T-base mutations, increased C:G transversions, decreased microhomology, and skewing toward short $S$ regions. Each of these claims is the direct opposite of the correct prediction derived from the foundational facts.\n**Verdict: Incorrect.**\n\n**C.** This option claims for $MSH2^{-/-}$ cells: a spectrum dominated by A:T changes, indistinguishable microhomology, and that MMR is the sole producer of CSR DSBs. The first claim contradicts the expected reduction in A:T mutations. The second claim is inconsistent with the role of MMR in repair coordination. The third claim is a fundamental factual error, as the problem explicitly describes the UNG-dependent pathway.\n**Verdict: Incorrect.**\n\n**D.** This option claims that $UNG^{-/-}$ and $MSH2^{-/-}$ phenotypes are identical because AID alone determines the outcome. This is fundamentally flawed. It ignores the central concept of the problem: that downstream processing of the initial AID-induced lesion by distinct repair pathways (UNG vs. MSH2) is what differentiates the outcomes. The phenotypes are demonstrably different, not identical.\n**Verdict: Incorrect.**\n\nBased on a rigorous analysis of the provided foundational principles, Option A is the only one that accurately predicts and differentiates the phenotypes of $UNG^{-/-}$ and $MSH2^{-/-}$ B cells.", "answer": "$$\\boxed{A}$$", "id": "2858698"}]}